Literature DB >> 11479400

Bacterial [correction of baterial] translocation in humans.

S M Lichtman1.   

Abstract

Bacterial translocation is a phenomenon in which live bacteria cross the intestinal barrier. The definition may be broadened to include transmural passage of bacterial cell wall components such as lipopolysaccharide and peptidoglycan polysaccharide. After translocation, bacteria or their products reach the mesenteric lymph nodes. From there, it is possible that enteric bacteria, their cell wall components, or both may disseminate throughout the body, causing sepsis, shock, multisystem organ dysfunction, or death of the host. Bacterial translocation and its complications have been shown clearly to occur in animal models, but its existence and importance in humans has been difficult to ascertain. The purpose of this review is to evaluate the data from studies in humans on the occurrence of bacterial translocation and, more importantly, to evaluate its role as a cause of death in humans. Studies from trauma and intensive care centers often imply that bacterial translocation is a major contributor to sepsis, shock, and multisystem organ failure in humans. However, the data reviewed herein do not support that view clearly. Carefully designed studies are needed to determine the relevance of bacterial translocation in human disease.

Entities:  

Mesh:

Year:  2001        PMID: 11479400     DOI: 10.1097/00005176-200107000-00001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  21 in total

Review 1.  The origin of human milk bacteria: is there a bacterial entero-mammary pathway during late pregnancy and lactation?

Authors:  Juan M Rodríguez
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

2.  Escherichia coli translocation in experimental short bowel syndrome: probiotic supplementation and detection by polymerase chain reaction.

Authors:  Inaki Eizaguirre; Pablo Aldazabal; Nerea Garcia Urkia; Anabel Asensio; Jose María García Arenzxana
Journal:  Pediatr Surg Int       Date:  2011-07-12       Impact factor: 1.827

3.  Low serum citrulline concentration correlates with catheter-related bloodstream infections in children with intestinal failure.

Authors:  Melissa A Hull; Brian A Jones; David Zurakowski; Bram Raphael; Clifford Lo; Tom Jaksic; Christopher Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-03       Impact factor: 4.016

4.  Obstructive jaundice promotes intestinal-barrier dysfunction and bacterial translocation: experimental study.

Authors:  Hesham Abdeldayem; Enas Ghoneim; Ahmad Ahmad-El Refaei; Ashraf Abou-Gabal
Journal:  Hepatol Int       Date:  2007-09-20       Impact factor: 6.047

5.  Fecal Microbiota Transplant Restores Mucosal Integrity in a Murine Model of Burn Injury.

Authors:  Joshua W Kuethe; Stephanie M Armocida; Emily F Midura; Teresa C Rice; David A Hildeman; Daniel P Healy; Charles C Caldwell
Journal:  Shock       Date:  2016-06       Impact factor: 3.454

6.  Propolis reduces bacterial translocation and intestinal villus atrophy in experimental obstructive jaundice.

Authors:  Mehmet Zafer Sabuncuoglu; Kemal Kismet; Sibel Serin Kilicoglu; Bulent Kilicoglu; Serap Erel; Sabahattin Muratoglu; Asli Elif Sunay; Esra Erdemli; Mehmet Ali Akkus
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 7.  Probiotics and human health: a clinical perspective.

Authors:  H S Gill; F Guarner
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

8.  Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery.

Authors:  Andreas Türler; Christoph Schnurr; Atsunori Nakao; Sandra Tögel; Beverley A Moore; Noriko Murase; Jörg C Kalff; Anthony J Bauer
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Increased Anti-Flagellin and Anti-Lipopolysaccharide Immunoglobulins in Pediatric Intestinal Failure: Associations With Fever and Central Line-Associated Bloodstream Infections.

Authors:  David P Galloway; Misty L Troutt; Samuel A Kocoshis; Andrew T Gewirtz; Thomas R Ziegler; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-06-04       Impact factor: 4.016

10.  A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.

Authors:  Douglas S Kalman; Howard I Schwartz; Patricia Alvarez; Samantha Feldman; John C Pezzullo; Diane R Krieger
Journal:  BMC Gastroenterol       Date:  2009-11-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.